SciELO - Scientific Electronic Library Online

 
vol.82 issue2From the prehypertensive adolescent to the hypertensive adult. Is possible to predict the conversion?The importance of myocardial blood flow quantification with positron emission tomography (PET) in patients with three-vessel disease author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Archivos de cardiología de México

On-line version ISSN 1665-1731Print version ISSN 1405-9940

Abstract

PAZ SOLDAN-PATINO, Claudia Patricia et al. Left main coronary aneurysm and antiphospholipid syndrome: survival at 12 years. A case report and literature review. Arch. Cardiol. Méx. [online]. 2012, vol.82, n.2, pp.120-124. ISSN 1665-1731.

Coronary artery aneurysms are a relatively infrequent finding with an incidence of 1% to 2% per year. Its cause can be atherosclerosis, congenital or due to other causes less common. Its initial manifestation can be myocardial infarction and sudden death as a result of rupture or distal embolization. The large coronary aneurysms, non-atherosclerotic, located in the common part of the left main coronary artery are exceptional. The diagnostic method of choice is the coronary angiography; however, non-invasive techniques such as transthoracic including tridimensional mode and transesophageal echocardiography, magnetic resonance imaging and computed tomography may have an important role in the detection and follow-up of these anomalies. The natural history of coronary aneurysm is not quite known. We present the case of a patient of 44 years, following an acute coronary event was diagnosed with an aneurysm in the left main and antiphospholipid syndrome. The patient received conservative treatment on the basis of antiplatelet and anticoagulant without presenting major cardiovascular events or other complications in 12 years of follow-up.

Keywords : Coronary aneurysm; Antiphospholipid syndrome; Conservative treatment; Anticoagulation; Antiplatelet; Mexico.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License